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Abstract
Dopaminergic innervation of the extended amygdala regulates anxiety-like behavior and stress
responsivity. A portion of this dopamine input arises from dopamine neurons located in the ventral
lateral periaqueductal gray (vlPAG) and rostral (RLi) and caudal linear nuclei of the raphe (CLi).
These neurons receive substantial norepinephrine input, which may prime them for involvement in
stress responses. Using a mouse line that expresses eGFP under control of the tyrosine
hydroxylase promoter, we explored the physiology and responsiveness to norepinephrine of these
neurons. We find that RLi dopamine neurons differ from VTA dopamine neurons with respect to
membrane resistance, capacitance and the hyperpolarization-activated current, Ih. Further, we
found that norepinephrine increased the frequency of spontaneous excitatory postsynaptic currents
(sEPSCs) on RLi dopamine neurons. This effect was mediated through the α1 adrenergic receptor
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(AR), as the actions of norepinephrine were mimicked by the α1-AR agonist methoxamine and
blocked by the α1-AR antagonist prazosin. This action of norepinephrine on sEPSCs was
transient, as it did not persist in the presence of prazosin. Methoxamine also increased the
frequency of miniature EPSCs, indicating that the α1-AR action on glutamatergic transmission
likely has a presynaptic mechanism. There was also a modest decrease in sEPSC frequency with
the application of the α2-AR agonist UK-14,304. These studies illustrate a potential mechanism
through which norepinephrine could recruit the activity of this population of dopaminergic
neurons.
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1. Introduction
Addiction exhibits significant comorbidity with mood and anxiety disorders, and stress is
frequently stated as a cause for drug use relapse (Sareen et al 2006, Sinha et al 1999, Sinha
& O'Malley 1999). The extended amygdala, which contains the bed nucleus of the stria
terminalis (BNST) and the central nucleus of the amygdala (CeA), has been shown to play
an important role in stress, anxiety, and addiction related behaviors (Davis et al 2010, Erb
2010, Koob 2009). Dopaminergic afferents in the extended amygdala are thought to regulate
anxiety-like behavior and stress responsivity (Meloni et al 2006). While dopamine is
classically regarded as a “reward” neurotransmitter, the firing of dopamine neurons
increases following acute stress, and dopamine has also been proposed to encode aspects of
aversive stimuli (Anstrom et al 2009, Anstrom & Woodward 2005, Brischoux et al 2009,
Coco et al 1992, Deutch et al 1991, Lammel et al 2011, Matsumoto & Hikosaka 2009,
Morrow et al 2000a). However, the impact of the midbrain dopamine system’s sensitivity to
stress is not well understood and requires further investigation.
Dopamine release in the extended amygdala has several actions. For example, in the CeA
and BNST dopamine enhances spontaneous glutamatergic transmission (Kash et al 2008,
Silberman & Winder 2013). In the BNST, dopamine decreases evoked glutamatergic and
inhibitory transmission (Krawczyk et al 2011a, Krawczyk et al 2011b), mediates a form of
long term potentiation at GABA synapses (Krawczyk et al 2013), decreases NMDA currents
in cocaine self-administering rats (Krawczyk et al 2014), and regulates long-term intrinsic
excitability of BNST neurons (Francesconi et al 2009). The BNST receives a substantial
proportion of its total dopaminergic input from the ventral lateral periaqueductal grey
(vlPAG) and the dorsal-caudal extension of the A10 dopamine cell group of the ventral
tegmental area (VTA), termed the A10dc cell group, which is located in the dorsal, rostral
linear (RLi), and caudal linear raphe nuclei (CLi) (Hasue & Shammah-Lagnado 2002,
Meloni et al 2006). The dopamine neurons of the lateral VTA have been extensively studied
while those of the A10dc group have often been overlooked. While overall very little is
known about A10dc roles and properties, evidence suggests that the RLi is particularly
sensitive to stressors (Deutch et al 1991).
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There is an increasing appreciation regarding the functional heterogeneity of dopamine
neurons. Electrophysiological properties of dopamine neurons, such as action potential
width and the presence of a hyperpolarization-activated current (Ih), differ based on their
projection targets and anatomical location (Lammel et al 2011, Li et al 2013, Margolis et al
2008). The modulation of excitatory synapses on dopamine neurons by aversive and
rewarding stimuli also depend on their projection targets (Lammel et al 2011). For example,
the dopamine neurons located in the medial posterior VTA, near the RLi, have no Ih and
their glutamatergic synapses are modified by aversive, but not rewarding stimuli (Lammel et
al 2011). Therefore, study of the basal electrophysiological properties of RLi dopamine
neurons may give early insights into their actions.
The noradrenergic system is a key regulator of the stress response. Many stressors increase
the firing of norepinephrine neurons and increase norepinephrine turnover in target regions
(Abercrombie et al 1988, Cecchi et al 2002, Korf et al 1973). The locus coeruleus, A1, A2,
and A5 norepinephrine groups send efferents to the RLi (Mejias-Aponte et al 2009).
Activation of α1 or α2 adrenergic receptors (ARs) induce changes in burst firing of VTA
dopamine neurons, (Grenhoff et al 1993, Grenhoff & Svensson 1989, Grenhoff & Svensson
1993, Guiard et al 2008) and glutamatergic transmission is crucial for burst firing of
dopamine neurons (Overton & Clark 1992, Seutin et al 1993). Norepinephrine acts as a
powerful modulator of excitatory neurotransmission in many limbic brain areas. Activation
of β, α1, and α2-ARs have been shown to enhance or attenuate glutamatergic transmission in
a variety of brain regions, including the hippocampus, CeA, BNST and VTA (Egli et al
2005, Flavin & Winder 2013, Gereau & Conn 1994, Jimenez-Rivera et al 2012, McElligott
et al 2010, McElligott & Winder 2008, Nobis et al 2011, Shields et al 2009, Velasquez-
Martinez et al 2012). Therefore, norepinephrine might modulate glutamatergic transmission
on RLi dopamine neurons.
Given the interconnections of the RLi with circuitry mediating stress and anxiety and the
stress sensitivity of RLi dopamine neurons, it is important to investigate the actions of
norepinephrine on RLi dopamine neurons. Using a tyrosine hydroxylase (TH)-eGFP reporter
mouse line, we found differences in basal electrophysiological properties, such as Ih,
membrane resistance and capacitance, of VTA and RLi dopamine neurons. We also
investigated the actions of norepinephrine on spontaneous glutamatergic transmission and
found an increase in the frequency of spontaneous excitatory postsynaptic currents (sEPSCs)
on RLi dopamine neurons. Through the application of specific AR agonists and antagonists,
we determined that this enhancement of excitatory transmission is due to the activation of
α1-ARs. α1-ARs also increased the frequency of miniature EPSCs indicating a potential
presynaptic locus for this modulation. In addition to this large α1-AR mediated enhancement
of excitatory transmission, we also found a modest α2-AR mediated depression of excitatory
transmission in RLi dopamine neurons.
2. Methods
2.1 Animals
Male mice ages 3–5 weeks were used in these experiments in accordance with animal use
protocol approved by the Institutional Animal Care and Use Committee of Vanderbilt
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University. All experiments were carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023).
Mice were group housed in the Vanderbilt vivarium under a 12 hour light/dark cycle with
food and water ad libitum. All mice were obtained from a transgenic mouse line (Strain
Name: STOCK Tg(Th-EGFP)DJ76Gsat/Mmnc). Mating pairs of mice were initially
obtained from the Mutant Mouse Regional Resource Center in North Carolina. In this mouse
line, the genome was modified to contain multiple copies of a modified BAC in which an
eGFP reporter gene was inserted immediately upstream of the coding sequence of the gene
for TH. Data presented here were obtained from two lineages of transgenic mice maintained
in-house, one derived by cross-breeding with Swiss Webster mice (Taconic), and the other
by cross-breeding with C57/B6 mice (Jackson Laboratories). The characterization of basal
electrophysiology properties was performed in mice with the Swiss Webster background.
The remainder of the electrophysiology studies and the immunohistochemistry were
performed in TH-eGFP mice that were backcrossed with C57/B6 mice for many
generations.
2.2 Immunohistochemistry & microscopy
Mice were transcardially perfused with ice-cold phosphate-buffered saline (PBS), followed
by ice-cold 4% paraformaldehyde in PBS. Brains were removed from the skull and post-
fixed in the same fixative overnight at 4°C, and were then transferred to 30% sucrose in
PBS. Two to five days later, 40 µm thick coronal sections of brain were sliced on a cryostat
(Leica CM3050S). Free-floating sections were washed in PBS (4 × 10 minutes),
permeabilized with 0.5% Triton-X 100 in PBS, and then blocked with 10% normal donkey
serum in PBS containing 0.1% Triton-X 100. Sections were then incubated with a mouse
monoclonal anti-TH antibody (from ImmunoStar used at 1:2000 dilution) in blocking
solution for 48 hours at 4°C, followed by PBS washes (4×10 minutes) and incubated with a
Cy3-conjugated donkey anti-mouse secondary antibody (from Jackson ImmunoResearch
used at 1:500 dilution) for 24 hours at 4°C in PBS with 0.1% Triton-X 100. Finally, sections
were washed (4×10 minutes), mounted on slides, sealed with PolyAquamount, and left
overnight to dry. Stained sections were examined with a Zeiss 510 scanning confocal
microscope.
2.3 Electrophysiology recordings
2.3.1 Brain slice preparation—3–5 week old TH-eGFP mice were decapitated under
Isoflurane anesthesia. The brains were quickly removed and placed in oxygenated ice-cold
sucrose artificial cerebrospinal fluid (ACSF): 194 mM sucrose, 20 mM NaCl, 4.4 mM KCl,
2 mM CaCl2, 1 mM MgCl2, 1.2 mM NaH2PO4, 10 mM glucose, and 26 mM NaHCO3.
Three-hundred µm coronal slices of the VTA or RLi were prepared using a vibrating
microtome (Leica VT 1200). Two RLi slices per mouse were generated. Slices were
incubated for 1 hour in oxygenated ACSF at 28°C: 124 mM NaCl, 2.5 mM KCl, 2.5 mM
CaCl2, 2 mM Mg2SO4, 1.25 mM NaH2PO4, 11 mM glucose, 26 mM NaHCO3, and 0.4mM
ascorbic acid. Slices then rested in a submerged superfusion chamber (Warner Instruments)
for 30 minutes prior to recordings.
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2.3.2 Whole-cell voltage clamp recordings—The TH-eGFP positive neurons were
identified via fluorescent microscopy, and directly visualized with infrared video
microscopy (Olympus) for patching. Recording electrodes were fabricated with a Flaming-
Brown Micropipette Puller (Sutter Instruments) using thin-walled borosilicate glass
capillaries (World Precision Instruments). Recording electrodes of resistance 2.5–5.5 MΩ
were filled with an internal solution of 290–295 mOsmol, pH = 7.2–7.3, consisting of: 125
mM K+-gluconate, 5 mM NaCl, 4.4 mM KCl, 10 mM HEPES, 0.6 mM EGTA, 4 mM ATP,
and 0.4 mM GTP for Ih current recordings and 117 mM Cs+-gluconate, 20 mM HEPES, 0.4
mM EGTA, 5mM TEA, 2mM MgCl2, 4 mM ATP, and 0.3 mM GTP for the remainder of
the electrophysiology recordings. All electrophysiology recordings were made using
Clampex 9.2 and analyzed using Clampfit 10.2 (Molecular Devices). Ih currents were
measured in the voltage-clamp recording configuration by stepping the holding potential
from −60mV to −120mV for 1 second and then measuring the difference between the
current immediately following the step to −120mV and the current at the end of the −120mV
step. Whole-cell, voltage-clamp recordings were performed as described previously (Egli et
al 2005, Kash et al 2008, Nobis et al 2011, Silberman & Winder 2013). Briefly, AMPA
receptor-mediated sEPSCs were made at −70 mV and pharmacologically isolated by the
addition of 25 µM picrotoxin to the ACSF. Cells were allowed to equilibrate to whole-cell
configuration for 5 min before recordings began. sEPSC recordings were acquired and
analyzed in 2 min gap-free blocks, and access resistance was monitored between blocks of
sEPSC recordings. Those experiments in which the access resistance changed by >20% were
not included in the data analyses. For the experiment in which the effect of prazosin was
determined, the antagonist was pre-applied for at least 15 minutes before application of
norepinephrine and then remained onboard for the duration of the experiment. To isolate
miniature EPSCs (mEPSCs) 1 uM tetrodotoxin (TTX) was added in addition to sEPSC
recording conditions.
2.4 Data analysis
2.4.1 Cell Counting—For counting single and multiply labeled neurons, z stacks of
imaged brain sections were projected onto a single plane using Zeiss LSM software.
Projected images were then opened in Metamorph and neurons counted with the help of
manual logger functions. The signal intensity threshold for counting neurons as positive for
a marker was set at twice that to the brightest neurons in no primary antibody control
sections (TH), or for eGFP, neurons in brainstem areas that did not express eGFP.
Quantitative data are expressed as mean ± S.E.M. unless otherwise noted.
2.4.2 Electrophysiology studies—Statistical analyses were performed using Microsoft
Excel 2010 and GraphPad Prism 6. Specifically, when comparisons were made between RLi
and VTA basal excitability properties, an unpaired Student’s t-test was used. When
determining whether a compound had a significant effect, a Student's paired t-test was used,
comparing the baseline value to the peak experimental value. Paired comparisons were made
between baseline (the average of the last three recording blocks before drug is added) and
the three recording blocks immediately following removal of drug application unless
otherwise noted. When comparing antagonist effects on the norepinephrine-induced increase
in sEPSCs, a repeated measures one-way ANOVA was used, followed by a Tukey’s post-
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test to determine the significance of specific comparisons. Degrees of freedom were
corrected using Greenhouse-Geisser estimates of sphericity. For the electrophysiology
studies, “n” refers to the number of cells. At least four animals were used in each
electrophysiology experiment. All values given throughout the study are presented as mean
± S.E.M.
2.5 Pharmacology
Isoproterenol hydrochloride, tetrodotoxin citrate, and picrotoxin were purchased from Tocris
Bioscience. Norepinephrine bitartrate salt monohydrate, methoxamine hydrochloride, and
prazosin hydrochloride were purchased from Sigma-Aldrich. All experimental drugs were
bath applied at their final concentrations as noted in the text. Dimethylsulfoxide (DMSO)
was the solvent used for stock solution of picrotoxin where the maximum final concentration
of DMSO in ACSF was 0.02% by volume. All other drugs, with the exception of prazosin,
were easily dissolved in water. Prazosin was dissolved in water with vigorous heating and
stirring.
3. Results
3.1 Electrophysiological characteristics of RLi dopamine neurons
We first wanted to confirm that the TH-eGFP mouse line would adequately report dopamine
neurons in the RLi. To examine this, sections were processed for immunostaining for anti-
TH and the numbers of eGFP+, TH+, and double labeled neurons were counted in images
captured from each section with a 20× lens. In the RLi, the percentage of eGFP+ cells that
were co-localized with TH+ cells was 95 ± 1% (n = 3) (Fig. 1B–E). These data suggest that
eGFP fluorescence in this mouse line is a good marker for dopamine neurons located in the
RLi.
It has been reported that dopamine neurons have distinct electrophysiological profiles based
on their projection targets and anatomical location (Lammel et al 2011, Margolis et al 2008).
Therefore, we examined the basic electrophysiological properties of eGFP positive neurons
located in the RLi and lateral VTA. Using whole-cell voltage clamp, we measured
membrane resistance, membrane capacitance, and hyperpolarization-activated (Ih) current of
TH-eGFP neurons in the RLi and VTA. RLi eGFP+ neurons exhibited a significantly higher
membrane resistance (745 ± 115 MΩ, n = 16) than eGFP+ neurons in the VTA (195 ± 53
MΩ, n = 10, p < 0.01) (Fig. 1F). Further, the RLi neurons also displayed a smaller
membrane capacitance (25 ± 2 pF, n = 16) than eGFP+ neurons in the VTA (56 ± 5 pF, n =
10, p < 0.0001) (Fig. 1G). Having established these differences in basic membrane
properties, we next sought to determine if the eGFP+ neurons in the RLi exhibit an Ih
current. The presence of Ih current has long been used as a marker for dopamine neurons in
the VTA (Hopf et al 2007, Margolis et al 2006, Stuber et al 2008). Recently, it has been
shown that a subset of dopamine neurons do not possess a robust Ih current (Lammel et al
2011, Margolis et al 2006, Margolis et al 2008). Consistent with this, we found that VTA
eGFP+ neurons displayed an Ih current similar to those observed in previous studies (−173 ±
46 pA, n = 10) (Ungless et al 2003). However, the eGFP+ neurons in the RLi had a
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significantly smaller Ih current (−14 ± 4 pA, p < 0.001, n = 16) when compared to the lateral
VTA (Fig. 1H–J), with most neurons lacking any measurable current.
3.2 Norepinephrine enhances spontaneous excitatory transmission on TH-eGFP+ neurons
in the RLi via activation of α1 adrenergic receptors
The RLi projects to regions heavily involved in stress responding and receives a large
noradrenergic projection (Mejias-Aponte et al 2009). Thus, we tested the hypothesis that
norepinephrine modulates RLi dopamine neurons. We first examined the effects of
norepinephrine on basal excitability and found no effect on holding current (107 ± 8% of
baseline, p > 0.05, n = 8) or membrane resistance (106 ± 6% of baseline, p > 0.05, n = 8).
Because norepinephrine has been shown to regulate excitatory drive in other brain regions,
we measured sEPSCs on TH-eGFP neurons located in the RLi (average basal frequency, 2.4
± 0.3 Hz; average basal amplitude, 20 ± 1 pA, n = 28) (Fig. 2A). We bath applied
norepinephrine (50 µM) for 10 minutes while spontaneous glutamatergic transmission was
monitored using whole cell patch-clamp recordings in acutely prepared brain slices. We
found that this norepinephrine application resulted in an increase in the frequency of sEPSCs
(473 ± 93% of basal frequency, p < 0.01, n = 8) (Fig. 2B). Additionally, there was a modest,
but significant effect on sEPSC amplitude (128 ± 11% of basal amplitude, p < 0.05, n = 8)
(Fig. 2C). This increase in amplitude was present during the last 5 minutes of
norepinephrine application. There was no effect of norepinephrine on sEPSC rise time (93 ±
7% of baseline, p > 0.05, n = 8) or decay time (97 ± 4% of baseline, p > 0.05, n = 8).
Since norepinephrine can act on multiple adrenergic receptors (ARs), we next tested whether
α1, α2, and/or β adrenergic receptors were responsible for the actions of norepinephrine on
glutamatergic transmission in RLi TH-eGFP neurons. We found that application of the α1-
AR agonist methoxamine (100 µM) increased sEPSC frequency (581 ± 169% of basal
frequency, p < 0.05, n = 9) (Fig. 3A) but not amplitude (117 ± 10% of basal amplitude, p =
0.10, n = 9) (Fig. 3B) in TH-eGFP positive neurons in the RLi. Preapplication of the α1-AR
antagonist prazosin (10 µM) prevented norepinephrine induced increases in sEPSC
frequency and amplitude. In fact, application of norepinephrine in the presence of prazosin
led to a decrease in sEPSC frequency (60 ± 6% of basal frequency, p < 0.01, n = 5) and a
modest, but significant, decrease in sEPSC amplitude (91 ± 2% of basal amplitude, p < 0.05,
n = 5) (Fig. 3C,D). To further investigate these decreases in sEPSC frequency and
amplitude, we bath-applied the α2-AR agonist UK-14,304. A 10 minute application of
UK-14,304 (1 µM) led to a significant decrease in sEPSC frequency (60 ± 9% of basal
frequency, p < 0.05, n = 6) with a trend toward a decrease in sEPSC amplitude (89 ± 5% of
basal amplitude, p = 0.08, n = 6) (Fig. 4A,B). Since activation of β-ARs can lead to increases
in sEPSC frequency in other brain regions such as the BNST, we bath-applied the β-AR
agonist isoproterenol (3 µM) for 10 minutes and found that this application of isoproterenol
did not lead to any changes in sEPSC frequency (104 ± 16% of basal frequency, p > 0.05, n
= 8) or amplitude (96 ± 5% of basal amplitude, p > 0.05, n = 8) (Fig. 4C,D). Taken together,
these data indicate that norepinephrine enhances the spontaneous glutamatergic transmission
in RLi TH-eGFP neurons via activation of α1-ARs.
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3.3 Noradrenergic enhancement of excitatory transmission on TH-eGFP+ RLi neurons is
transient
To further investigate the time course of norepinephrine’s enhancement of excitatory
transmission in RLi TH-eGFP neurons, we bath applied prazosin (10 µM) to slices 10
minutes after a 10 minute application of norepinephrine was completed. The prazosin was
able to reverse the increase in frequency of sEPSCs caused by norepinephrine (Fig. 5A,C)
(F(1.041, 5.206) = 8.935, p < 0.05, n = 6). It also reduced the modest increase in amplitude
of sEPSCs caused by norepinephrine (Fig. 5B,D) (F(1.622, 8.111) = 13.48, p < 0.01, n = 6).
These results indicate that the increase in glutamatergic transmission in RLi TH-eGFP
neurons is not due to long term potentiation of excitatory inputs but rather from transient
effects of α1-AR activation.
3.4 α1-AR activation increases glutamatergic transmission in an activity-independent
manner
To further investigate the mechanism of action of norepinephrine’s effects on RLi TH-eGFP
neurons, we examined the ability of methoxamine to modulate activity-independent
miniature EPSCs (mEPSCs). mEPSCs were isolated by the addition of the sodium channel
blocker TTX (1µM) to the bath solution (average basal frequency, 1.8 ± 0.8 Hz; average
basal amplitude 15 ± 1 pA, n = 7). We found that methoxamine enhanced mEPSC frequency
(535 ± 128% of basal frequency, p < 0.05, n = 7) (Fig 6A–C), but had no effect on mEPSC
amplitude (112 ± 6% of basal amplitude, n = 7) (Fig. 6D) in RLi TH-eGFP neurons. These
results indicate that the α1-AR induced enhancement of glutamatergic transmission in RLi
TH-eGFP neurons occurs via an activity-independent mechanism and provide evidence that
norepinephrine’s site of action on RLi TH-eGFP neurons is presynaptic.
4. Discussion
Because of the small size of the RLi coupled with the lack of Ih in RLi dopamine neurons, a
reporter method is necessary to identify these neurons for electrophysiological analysis.
Thus we analyzed the properties of these neurons in a TH-eGFP line previously utilized for
analysis of dopamine neurons (Li et al 2013). In an initial characterization of the basic
membrane properties of eGFP positive neurons in the RLi of these transgenic mice, we
found several significant differences as compared to eGFP positive lateral VTA neurons.
The dopamine neurons in the RLi had a significantly greater membrane resistance when
compared to the dopamine neurons in the VTA. Additionally, we found that the capacitance
was significantly smaller in the RLi neurons. Finally, we found little to no Ih current in the
RLi dopamine neurons. Other groups have also found a lack of Ih current in dopamine
neurons with anatomical locations near the midline (Lammel et al 2011, Li et al 2013).
Functionally, these properties are expected to affect differences in excitability and may
influence plasticity of synaptic transmission. Our findings suggest fundamental differences
in the basic membrane and excitability properties between the afferent dopaminergic
projections to the BNST from the VTA and RLi. These findings raise the possibility that
these neurons may exhibit different firing patterns in vivo and thus be regulated differently
by exposure to stressors or drugs of abuse.
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Norepinephrine acts as a powerful modulator of excitatory neurotransmission in many brain
areas. We found that the most pronounced effect of norepinephrine on RLi dopamine neuron
physiology was an increase in the frequency of sEPSCs. Since activation of β-ARs increases
excitatory transmission in the hippocampus, CeA, and BNST, we attempted to mimic the
effects of norepinephrine with the β-AR agonist isoproterenol (Egli et al 2005, Gereau &
Conn 1994, Nobis et al 2011). However, isoproterenol had no effect on sEPSC frequency or
amplitude.
In the BNST, activation of α1-ARs elicits long term depression of evoked glutamatergic
transmission, but an increase in sEPSCs. Similarly, activation of α1-ARs leads to an
enhancement of glutamatergic transmission onto VTA dopamine neurons (McElligott et al
2010, McElligott & Winder 2008, Velasquez-Martinez et al 2012). In the presence of the α1-
AR antagonist prazosin, we found that norepinephrine did not increase excitatory
transmission. In fact, when α1-ARs were blocked, norepinephrine decreased sEPSC
frequency and amplitude. Since the α2-AR agonist UK-14,304 led to a depression of sEPSC
frequency and a trend toward a decrease in sEPSC amplitude, this decrease in excitatory
transmission is likely due to the activation of α2-ARs. Similarly, activation of α2-ARs
decreases excitatory transmission in the BNST and onto VTA dopamine neurons (Egli et al
2005, Jimenez-Rivera et al 2012, Shields et al 2009). It is possible that this decrease in
glutamatergic transmission is also due to the blockade of tonically active α1-ARs (Grenhoff
& Svensson 1993). However, the timing of the effect coincides with norepinephrine
application which supports α2-AR activation mediating this decrease in excitatory
transmission. It is important to note that the overall effect of norepinephrine on RLi
dopamine neurons is an increase in excitatory transmission and the small decrease in sEPSC
frequency is surpassed by the large α1-AR mediated increase in sEPSC frequency.
Since the effect of norepinephrine on sEPSC frequency was blocked by the α1-AR
antagonist, we attempted to mimic it with the α1-AR agonist methoxamine. Indeed,
methoxamine mimicked the effects of norepinephrine on RLi sEPSC frequency. This
finding is a similar to that seen in VTA dopamine neurons (Velasquez-Martinez et al 2012).
In the RLi, the frequency of mEPSCs increases with the activation of α1-ARs. The increase
in mEPSC frequency indicates that α1-ARs may act presynaptically to increase excitatory
transmission on RLi dopamine neurons and that their actions are independent of presynaptic
action potentials. While activation of α1-ARs in VTA dopamine cells does not modulate
mEPSCs, activation of α1-ARs in other brain regions, such as the hypothalamus, does lead
to an increase in mEPSC frequency (Gordon & Bains 2003). The VTA dopamine neurons
were identified via a large Ih current (> 200 pA) and are located more laterally, while the
RLi dopamine neurons have very small, almost negligible, Ih current and are located along
the midline. Therefore, these are entirely different populations of dopamine neurons which
may differ in their response to inputs and outputs to projection targets. Both the lateral VTA
and the RLi receive noradrenergic inputs from the locus coeruleus (LC) and the
norepinephrine brainstem centers, A1, A2 and A5 (Mejias-Aponte et al 2009). However, the
lateral VTA has a higher percentage of its norepinephrine input arising from the LC, while
the RLi has a higher percentage of its norepinephrine input arising from the brainstem
centers. This might lead to differences in how these two groups of dopamine neurons
respond to stimuli, such as stress, that lead to the release of norepinephrine in target regions.
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This study indicates a potential mechanism through which norepinephrine could recruit the
activity of RLi dopamine neurons. Since activation of glutamatergic afferents mediates the
firing of dopamine neurons, we would expect this α1-AR mediated enhancement in
excitatory transmission to increase the firing of dopamine neurons and release of dopamine
in target regions. Stressors have been shown to increase dopamine concentration in many
target regions (Abercrombie et al 1989, Deutch et al 1991, Kalivas & Duffy 1995, Morrow
et al 2000b, Sutoo & Akiyama 2002). Stress causes norepinephrine release, which our data
suggests would lead to an increase in excitatory drive on RLi dopamine neurons via α1-AR
activation. One possibility is that this drives dopamine release in target regions such as the
BNST, where it may participate in reinforcement related behaviors as well as anxiety
responses. Thus norepinephrine induced enhancement of excitatory drive on RLi dopamine
neurons is a potential mechanism through which RLi dopamine neurons may be involved in
the stress response.
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• RLi dopamine neurons have distinct basal excitability profiles.
• Norepinephrine enhances spontaneous glutamate release onto RLi dopamine
neurons.
• α1-AR activation enhances spontaneous glutamate release onto RLi dopamine
neurons.
• α1-AR’s effects on excitatory transmission are transient and activity
independent.
• α2-AR activation decreases spontaneous glutamate release onto RLi dopamine
neurons.
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RLi dopamine neurons have distinct basal excitability profiles. (A) Diagram of a coronal
brain section image from Franklin & Paxinos mouse atlas showing region selected for VTA
electrophysiology recordings. (B) Diagram of a coronal brain section image from Franklin &
Paxinos mouse atlas showing region selected for RLi electrophysiology recordings. (C)
Coronal section of the RLi corresponding to the black rectangle in B displaying eGFP
fluorescence, (D) tyrosine hydroxylase immunohistochemistry, and (E) the merged image
showing the co-localization of eGFP and tyrosine hydroxylase labeled neurons. The arrows
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highlight examples of double labeled cells. (F) Bar graph showing the membrane resistance
of eGFP positive neurons in the RLi and VTA. The eGFP positive neurons in the RLi
exhibited a significantly higher membrane resistance compared to those in the VTA (**
denotes p < 0.01). (G) Bar graph showing the capacitance of eGFP positive neurons in the
RLi and VTA. The eGFP positive neurons in the RLi exhibited a significantly reduced
capacitance compared to those in the VTA (**** denotes p < 0.0001). (H) Bar graph
comparing the average peak Ih current for each group of dopamine neurons. There was a
significant difference in the Ih current in the VTA dopamine neurons compared to dopamine
neurons in the RLi (*** denotes p < 0.001). (I) A hyperpolarization voltage step in an eGFP
positive neuron in the VTA leads to a robust inward current. (J) A hyperpolarization voltage
step in an eGFP positive neuron in the RLi leads to a small but measureable inward current.
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Norepinephrine increases spontaneous glutamatergic transmission onto RLi dopamine
neurons. (A) Representative sEPSC recordings in the RLi demonstrating the ability of
norepinephrine (NE) to enhance glutamatergic transmission. (B) A 10 min application of 50
µM norepinephrine increases sEPSC frequency onto RLi dopamine neurons. (C) A 10 min
application of 50 µM norepinephrine modestly increases sEPSC amplitude onto RLi
dopamine neurons only during the last 5 minutes of drug application.
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Activation of α1-ARs increases sEPSC frequency onto RLi dopamine neurons. (A) A 20
min application of 100 µM methoxamine (methox) increases sEPSC frequency onto RLi
dopamine neurons. (B) A 20 min application of 100 µM methoxamine has no effect on
sEPSC amplitude onto RLi dopamine neurons. (C) In the presence of the α1-AR antagonist
prazosin (10 µM), a 10 min application of 50 µM norepinephrine decreases the frequency of
sEPSCs onto RLi dopamine neurons. (D) In the presence of the α1-AR antagonist prazosin
(10 µM), a 10 min application of 50 µM norepinephrine modestly decreases the amplitude of
sEPSCs onto RLi dopamine neurons.
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α2-AR activation depresses glutamatergic transmission and β-AR activation has no effect on
glutamatergic transmission onto RLi dopamine neurons. (A) A 10 min application of 1 µM
UK-14,304 decreases sEPSC frequency onto RLi dopamine neurons. (B) A 10 min
application of 1 µM UK-14,304 causes a trend toward a decrease in sEPSC amplitude onto
RLi dopamine neurons. (C) A 10 min application of 3 µM isoproterenol (Iso) has no effect
on sEPSC frequency or (D) sEPSC amplitude onto RLi dopamine neurons.
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Norepinephrine’s actions on sEPSCs are transient. (A,C) The norepinephrine induced
increase in sEPSC frequency does not persist when followed by a 15 min application of 10
µM prazosin (* denotes p < 0.05). (B,D) The norepinephrine induced increase in sEPSC
amplitude does not persist when followed by a 15 min application of 10 µM prazosin (**
denotes p < 0.01).
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Methoxamine increases mEPSC frequency but not amplitude. (A) Representative mEPSC
recordings in the RLi demonstrating the ability of methoxamine to enhance glutamatergic
transmission. (B) A representative experiment showing the effect of 100 µM methoxamine
on mEPSC frequency onto RLi dopamine neurons. (C) A 20 min application of 100 µM
methoxamine increases mEPSC frequency onto RLi dopamine neurons (* denotes p < 0.05).
(D) A 20 min application of 100 µM methoxamine has no effect on mEPSC amplitude onto
RLi dopamine neurons.
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